Emma Burgos Ramos (ORCID: 0000-0002-6942-3023) obtained her Ph.D. in Biology from the University of Alcalá (Madrid) in late 2006, analyzing the effects of several drugs on the somatostatin receptor-effector system in an animal experimental model of Alzheimer’s disease. In 2007, she joined the Laboratory of Endocrinology and Nutrition at Hospital Infantil Universitario Niño Jesús (Madrid) as a postdoctoral researcher, under the supervision of Vicente Barrios Sabador, Ph.D. During that time, she was a member of the Obesity and Nutrition CIBER and held a Postdoctoral Sara Borrell contract, studying the regulation of leptin and insulin intracellular signaling mechanisms both in the central nervous system and in peripheral tissues, which regulate energy homeostasis in the pathogenesis of obesity and type 2 diabetes. This contract also allowed her to undertake two stays at centers of excellence: the Metabolic Research Laboratory at the Universidad Clínica de Navarra (Pamplona) and the Edison Biotechnology Institute at Ohio University (USA), where she carried out microarray profiles and proteomic analysis, respectively.
In 2013, she joined CNIO (Madrid) in the cancer stem cells group directed by Professor Christopher Heeschen, participating in the metabolic characterization of stem cells from pancreatic tumors. In 2014, she worked at IMDEA Food Institute (Madrid) as a junior researcher in the Laboratory of Functional Foods, where she started to study the effects of different nutraceuticals on health. Simultaneously, she joined as an adjunct professor at the Faculty of Environmental Sciences and Biochemistry at UCLM. In 2022, she secured a permanent position as an Associate Professor of Biochemistry and Molecular Biology at the same university. Her research focuses on analyzing the effects of hydroxytyrosol on neurodegenerative and metabolic disorders. To date, she has published more than forty-two research papers and participated in more than fifty-four conferences..
